Acceleron Pharma

Investors/Media

Press Releases

Date Title and Summary View
Toggle Summary Acceleron Pharma Appoints Matthew L. Sherman, M.D. as Chief Medical Officer
Dr. Sherman’s Expertise in Building a Clinical Development Organization and Advancing Programs Through Regulatory Approval a Key Addition to the Management Team
View HTML
Toggle Summary Acceleron Pharma Appoints Glenn Batchelder as CEO and Adds Richard F. Pops to Board of Directors
Acceleron Pharma Appoints Glenn Batchelder as CEO and Adds Richard F. Pops to Board of Directors CAMBRIDGE, MA – June 14, 2004 – Acceleron Pharma announced today the appointment of Glenn Batchelder as president and CEO and a member of the board of directors.
View HTML
Toggle Summary Acceleron Pharma, Developing Drugs to Treat Musculoskeletal and Metabolic Disorders, Secures $25 Million in Series A Funding
Acceleron Pharma, Developing Drugs to Treat Musculoskeletal and Metabolic Disorders, Secures $25 Million in Series A Funding BOSTON, MA – February 13, 2004 – Acceleron Pharma, a biopharmaceutical company developing drugs to treat musculoskeletal and metabolic disorders, announced today that it has
View HTML